Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, open-label study of the effect of different doses of pertuzumab on treatment response in patients with metastatic breast cancer with low HER2 expression
Pertuzumab
BO16934
malignant neoplasm of breast
Phase 2
 
January 2015

Powered by ideaPoint, Inc.